Which coronary lesions should be treated with a drug eluting stent? A model-based cost-effectiveness analysis

被引：0
|
作者：
Carlier, SG [1 ]
Berger, A [1 ]
De Backer, TL [1 ]
Heyndrickx, G [1 ]
Wijns, W [1 ]
机构：
[1] Cardiovasc Cntr Aalst, Aalst, Belgium
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1886
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [1] A cost-effectiveness analysis of taxus™ drug-eluting stent in the UK
    Wenk-Lang, A
    Knight, C
    VALUE IN HEALTH, 2003, 6 (06) : 661 - 661
  • [2] Estimated cost-effectiveness of the TAXUS™ paclitaxel-eluting coronary stent
    Lacey, MJ
    Clark, MA
    Halpern, MT
    Cohen, DJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 26L - 26L
  • [3] Cost-effectiveness of drug-coated balloon angioplasty and drug-eluting stent implantation for treatment of coronary in-stent restenosis
    Dorenkamp, M.
    Leber, A.
    Sohns, C.
    Boldt, L.
    Roser, M.
    Kleber, F.
    Haverkamp, W.
    Bonaventura, K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 840 - 841
  • [4] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    G. B. Gomez
    D. W. Dowdy
    M. L. Bastos
    A. Zwerling
    S. Sweeney
    N. Foster
    A. Trajman
    M. A. Islam
    S. Kapiga
    E. Sinanovic
    G. M. Knight
    R. G. White
    W. A. Wells
    F. G. Cobelens
    A. Vassall
    BMC Infectious Diseases, 16
  • [5] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    Gomez, G. B.
    Dowdy, D. W.
    Bastos, M. L.
    Zwerling, A.
    Sweeney, S.
    Foster, N.
    Trajman, A.
    Islam, M. A.
    Kapiga, S.
    Sinanovic, E.
    Knight, G. M.
    White, R. G.
    Wells, W. A.
    Cobelens, F. G.
    Vassall, A.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [6] Cost-effectiveness of drug-eluting coronary stents in Quebec, Canada
    Brophy, JM
    Erickson, LJ
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2005, 21 (03) : 326 - 333
  • [7] A MODEL-BASED COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL PHARMACOGENOMIC TESTING
    Lubomirov, R.
    Borobia, A. M.
    Carcas, A. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 33 - 33
  • [8] A model-based cost-effectiveness analysis of Patient Blood Management
    Kleinerueschkamp, Adina
    Meybohm, Patrick
    Straub, Niels
    Zacharowski, Kai
    Choorapoikayil, Suma
    BLOOD TRANSFUSION, 2019, 17 (01) : 16 - 26
  • [9] Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents
    Konstantinos Katsanos
    Dimitris Karnabatidis
    Athanasios Diamantopoulos
    Stavros Spiliopoulos
    Dimitris Siablis
    CardioVascular and Interventional Radiology, 2013, 36 : 90 - 97
  • [10] Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents
    Katsanos, Konstantinos
    Karnabatidis, Dimitris
    Diamantopoulos, Athanasios
    Spiliopoulos, Stavros
    Siablis, Dimitris
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (01) : 90 - 97
12345